KeyBank National Association’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.59M | Buy |
37,361
+2,668
| +8% | +$145K | 0.01% | 531 |
|
|
2026
Q1 | $2.18M | Buy |
34,693
+7,697
| +29% | +$616K | 0.01% | 437 |
|
|
2025
Q4 | $2.57M | Buy |
26,996
+3,785
| +16% | +$371K | 0.01% | 395 |
|
|
2025
Q3 | $2.27M | Buy |
23,211
+6,992
| +43% | +$724K | 0.01% | 425 |
|
|
2025
Q2 | $1.74M | Buy |
16,219
+493
| +3% | +$49.9K | 0.01% | 466 |
|
|
2025
Q1 | $1.59M | Sell |
15,726
-3
| -0% | -$302 | 0.01% | 466 |
|
|
2024
Q4 | $1.4M | Buy |
15,729
+276
| +2% | +$24.3K | 0.01% | 482 |
|
|
2024
Q3 | $1.29M | Buy |
15,453
+868
| +6% | +$68.4K | 0.01% | 499 |
|
|
2024
Q2 | $1.12M | Buy |
14,585
+688
| +5% | +$50.4K | ﹤0.01% | 509 |
|
|
2024
Q1 | $952K | Buy |
13,897
+767
| +6% | +$49.3K | ﹤0.01% | 549 |
|
|
2023
Q4 | $759K | Sell |
13,130
-4,480
| -25% | -$239K | ﹤0.01% | 596 |
|
|
2023
Q3 | $930K | Buy |
17,610
+5,259
| +43% | +$276K | ﹤0.01% | 492 |
|
|
2023
Q2 | $668K | Sell |
12,351
-2,373
| -16% | -$124K | ﹤0.01% | 608 |
|
|
2023
Q1 | $737K | Buy |
14,724
+2,237
| +18% | +$105K | ﹤0.01% | 551 |
|
|
2022
Q4 | $578K | Buy |
12,487
+1,440
| +13% | +$62.4K | ﹤0.01% | 641 |
|
|
2022
Q3 | $428K | Buy |
11,047
+20
| +0.2% | +$802 | ﹤0.01% | 714 |
|
|
2022
Q2 | $411K | Sell |
11,027
-481
| -4% | -$19.6K | ﹤0.01% | 747 |
|
|
2022
Q1 | $510K | Buy |
11,508
+1,091
| +10% | +$47.3K | ﹤0.01% | 715 |
|
|
2021
Q4 | $443K | Sell |
10,417
-1,565
| -13% | -$65.8K | ﹤0.01% | 825 |
|
|
2021
Q3 | $520K | Buy |
11,982
+2,518
| +27% | +$111K | ﹤0.01% | 785 |
|
|
2021
Q2 | $405K | Buy |
9,464
+1,397
| +17% | +$58.8K | ﹤0.01% | 847 |
|
|
2021
Q1 | $312K | Buy |
8,067
+810
| +11% | +$30.7K | ﹤0.01% | 911 |
|
|
2020
Q4 | $261K | Buy |
7,257
+515
| +8% | +$18.6K | ﹤0.01% | 941 |
|
|
2020
Q3 | $258K | Sell |
6,742
-5,378
| -44% | -$207K | ﹤0.01% | 875 |
|
|
2020
Q2 | $426K | Sell |
12,120
-331
| -3% | -$11.9K | ﹤0.01% | 719 |
|
|
2020
Q1 | $406K | Sell |
12,451
-738
| -6% | -$28.8K | ﹤0.01% | 683 |
|
|
2019
Q4 | $596K | Buy |
13,189
+266
| +2% | +$11.1K | ﹤0.01% | 681 |
|
|
2019
Q3 | $526K | Sell |
12,923
-780
| -6% | -$33K | ﹤0.01% | 695 |
|
|
2019
Q2 | $589K | Sell |
13,703
-245
| -2% | -$9.42K | ﹤0.01% | 700 |
|
|
2019
Q1 | $535K | Sell |
13,948
-1,253
| -8% | -$47.9K | ﹤0.01% | 703 |
|
|
2018
Q4 | $537K | Buy |
15,201
+1,106
| +8% | +$40.1K | ﹤0.01% | 648 |
|
|
2018
Q3 | $543K | Sell |
14,095
-2,547
| -15% | -$89K | ﹤0.01% | 745 |
|
|
2018
Q2 | $544K | Buy |
16,642
+3,508
| +27% | +$106K | ﹤0.01% | 717 |
|
|
2018
Q1 | $359K | Sell |
13,134
-1,797
| -12% | -$48.8K | ﹤0.01% | 841 |
|
|
2017
Q4 | $370K | Sell |
14,931
-13,026
| -47% | -$359K | ﹤0.01% | 832 |
|
|
2017
Q3 | $816K | Sell |
27,957
-795
| -3% | -$22K | ﹤0.01% | 635 |
|
|
2017
Q2 | $797K | Buy |
28,752
+1,277
| +5% | +$33.9K | ﹤0.01% | 666 |
|
|
2017
Q1 | $683K | Buy |
27,475
+2,805
| +11% | +$68.2K | ﹤0.01% | 723 |
|
|
2016
Q4 | $534K | Sell |
24,670
-1,336
| -5% | -$29.2K | ﹤0.01% | 787 |
|
|
2016
Q3 | $619K | Buy |
26,006
+286
| +1% | +$6.82K | ﹤0.01% | 759 |
|
|
2016
Q2 | $601K | Sell |
25,720
-1,149
| -4% | -$24.9K | ﹤0.01% | 720 |
|
|
2016
Q1 | $505K | Buy |
26,869
+475
| +2% | +$8.34K | ﹤0.01% | 770 |
|
|
2015
Q4 | $487K | Buy |
26,394
+336
| +1% | +$6.02K | ﹤0.01% | 781 |
|
|
2015
Q3 | $428K | Buy |
26,058
+947
| +4% | +$16.2K | ﹤0.01% | 825 |
|
|
2015
Q2 | $444K | Sell |
25,111
-150
| -0.6% | -$2.68K | ﹤0.01% | 861 |
|
|
2015
Q1 | $448K | Sell |
25,261
-2,335
| -8% | -$36.9K | ﹤0.01% | 902 |
|
|
2014
Q4 | $366K | Buy |
27,596
+1,567
| +6% | +$20K | ﹤0.01% | 964 |
|
|
2014
Q3 | $307K | Sell |
26,029
-847
| -3% | -$10.7K | ﹤0.01% | 1032 |
|
|
2014
Q2 | $343K | Sell |
26,876
-2,206
| -8% | -$28.7K | ﹤0.01% | 1045 |
|
|
2014
Q1 | $393K | Sell |
29,082
-504
| -2% | -$6.62K | ﹤0.01% | 988 |
|
|
2013
Q4 | $356K | Sell |
29,586
-1,111
| -4% | -$13.1K | ﹤0.01% | 1020 |
|
|
2013
Q3 | $360K | Sell |
30,697
-30,061
| -49% | -$325K | ﹤0.01% | 979 |
|
|
2013
Q2 | $563K | Buy |
+60,758
| New | +$515K | ﹤0.01% | 954 |
|
Other funds holding BSX
KeyBank National Association's BSX Position: Q2 2026 in Review
KeyBank National Association increased its Boston Scientific (BSX) stake by 7.7% in Q2 2026, buying an estimated $145K and bringing the position to 37,361 shares worth $1.59M. The position accounts for 0.01% of the portfolio, ranked #531.
KeyBank National Association first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.57M in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- KeyBank National Association held 37,361 shares of Boston Scientific worth $1.59M as of Q2 2026.
- KeyBank National Association bought 2,668 Boston Scientific shares in Q2 2026, an estimated $145K.
- Boston Scientific made up 0.01% of KeyBank National Association's portfolio in Q2 2026, its #531 holding.
- KeyBank National Association first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
- KeyBank National Association's Boston Scientific position peaked at $2.57M in Q4 2025.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.